Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback

Yaxi Chen1, Halcyon Ku, Lei Zhao

  • 1From the Key Laboratory of Metabolism on Lipid and Glucose, Centre for Lipid Research, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (Y.C., L.Z., Q.L., A.H., X.Z.R.); Division of Nephrology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (L.C.L.); and John Moorhead Research Laboratory, Centre for Nephrology, University College London (UCL) Medical School, United Kingdom (H.K., D.C.W., Z.V., J.F.M., S.H.P., X.Z.R.).

Insights

Chronic inflammation increases cardiovascular disease risk and may cause statin resistance by boosting cholesterol synthesis via HMGCoA-R. This study found inflammatory stress weakens statin effectiveness, potentially explaining lipid accumulation and treatment failure.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Pharmacology

Background:

  • Chronic inflammatory states significantly elevate cardiovascular disease risk.
  • Standard statin doses may offer reduced cardiovascular protection in inflamed patients.
  • Inflammation-induced increases in cholesterol synthesis might be resistant to statins.

Purpose of the Study:

  • To investigate if inflammation-induced 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCoA-R) cholesterol synthesis is statin-resistant.
  • To determine if the sterol regulatory element binding protein cleavage-activating protein (SREBP-CA) pathway mediates this statin resistance.

Main Methods:

  • Induced inflammation in vitro (cytokines, LPS) and in vivo (triple knockout mice).
  • Assessed HMGCoA-R mRNA, protein, and enzymatic activity.
  • Utilized atorvastatin, SREBP-CA knockdown, and overexpression to study pathway involvement.
  • Measured serum cholesterol and aortic lipid accumulation in mice.

Main Results:

  • Inflammatory stress exacerbated cholesterol ester accumulation and increased HMGCoA-R expression via SREBP-CA/SREBP-2.
  • Atorvastatin's inhibition of HMGCoA-R activity and cholesterol synthesis was reduced under inflammatory conditions.
  • SREBP-CA knockdown prevented statin resistance; its overexpression induced resistance.
  • Higher atorvastatin doses were required in vivo to reduce cholesterol and lipids during inflammation.

Conclusions:

  • Elevated HMGCoA-R-mediated cholesterol synthesis under inflammation is a key mechanism for intracellular lipid accumulation.
  • This pathway contributes to statin resistance in inflammatory states.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Inflammation01:38

Inflammation

Overview
46.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
758
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K